PSMD10 and neoplasm: In a previous study, with repeated ankyrin domains, Gankyrin, as an oncoprotein can recruit a MDM2/p53 complex to the 26S proteasome and boost the degradation of p53 with the help of MDM2, thus leading to a tumor-prone phenotype [8].